Photochemical Internalization Using Natural Anticancer Drugs, Antimetabolites, and Nanoformulations: A Systematic Study against Breast and Pancreatic Cancer Cell Lines
Molecular Pharmaceutics · 2023
DOI: 10.1021/acs.molpharmaceut.2c01012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2023. Verfasst von Christopher Barnett und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy Brunswick Square, University College London, London WC1N 1AX, U.K. Hauptthemen laut MEDLINE: Antineoplastic Agents, Vinca Alkaloids, Pancreatic Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Engineering and Physical Sciences Research Council, University of Patras.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy Brunswick Square, University College London, London WC1N 1AX, U.K.
- Department of Chemical Engineering, University of Patras, Patras 26504, Greece.
ORCID-Profile: George Pasparakis
Förderung
- Engineering and Physical Sciences Research Council
- University of Patras
Zitieren
APA
Barnett, C., Joubert, F., Iliopoulou, A., Álvarez, R. S., & Pasparakis, G. (2023). Photochemical Internalization Using Natural Anticancer Drugs, Antimetabolites, and Nanoformulations: A Systematic Study against Breast and Pancreatic Cancer Cell Lines. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.2c01012
Vancouver
Barnett C, Joubert F, Iliopoulou A, Álvarez RS, Pasparakis G. Photochemical Internalization Using Natural Anticancer Drugs, Antimetabolites, and Nanoformulations: A Systematic Study against Breast and Pancreatic Cancer Cell Lines. Molecular Pharmaceutics. 2023. doi:10.1021/acs.molpharmaceut.2c01012
BibTeX
@article{Barnett2023,
author = {Barnett, Christopher and Joubert, Fanny and Iliopoulou, Alexandra and Álvarez, Raúl Sánchez and Pasparakis, George},
title = {Photochemical Internalization Using Natural Anticancer Drugs, Antimetabolites, and Nanoformulations: A Systematic Study against Breast and Pancreatic Cancer Cell Lines},
journal = {Molecular Pharmaceutics},
year = {2023},
doi = {10.1021/acs.molpharmaceut.2c01012}
}
EUVIMED